Hirschsprung’s Disease Treatment Market: Introduction

  • Hirschsprung’s disease, also called congenital aganglionic megacolon, is a disease commonly recognized in newborns and infants. However, symptoms of Hirschsprung’s disease may be missed until adolescent period or even late adulthood. Hirschsprung’s disease is caused by failed migration of colonic ganglion cells during gestation.

To gauge the scope of customization in our reports, Ask for a Sample

Key Drivers and Restraints of Global Hirschsprung’s Disease Treatment Market

  • Rise in prevalence of cardiovascular diseases and surgery boosts the growth of the global market. The global prevalence could vary by region and has been shown to be as high as 1 per 3,000 live births in the Federated States of Micronesia. The cause of Hirschsprung’s disease is multifactorial. The disease can be familial or develop spontaneously, and is more common in boys than girls. Approximately 3% to 5% of male siblings and 1% of female siblings of children with short-segment disease could also have the disease. Hirschsprung’s disease can also be associated with neurologic, cardiovascular, urologic, and gastrointestinal abnormalities. Down syndrome is the most common chromosomal abnormality associated with the disease, accounting for around 10% of patients.
  • However, lack of definitive treatment options & misdiagnosis of the disease and limited access to health care services in various countries are projected to hamper the growth of the global market

Are you a start-up willing to make it big in the business? Grab an exclusive PDF Brochure of this report

Surgery Segment to Dominate Global Hirschsprung’s Disease Treatment Market

  • In terms of treatment type, the global Hirschsprung’s disease treatment market can be bifurcated into surgery and medication. The medication segment can be split into antibiotics, toxins (onabotulinumtoxina), and others.
  • The surgery segment dominated the global Hirschsprung’s disease treatment market in terms of revenue in 2019 and the trend is anticipated to continue during the forecast period. Hirschsprung’s disease is a life-threatening illness and treatment requires surgery. After surgery, the patient feels better and growth typically improves, which was slowed down because of Hirschsprung’s disease. Either pull-through procedure or an ostomy surgery is performed, in which all or part of the colon could be removed during surgery.

North America to Lead Global Hirschsprung’s Disease Treatment Market

  • In terms of region, the global Hirschsprung’s disease treatment market can be segment into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • In terms of revenue, North America dominated the global Hirschsprung’s disease treatment market in 2019, followed by Europe. Rise in prevalence of Hirschsprung’s disease and adoption of various treatment modalities drive the market in North America. According to data published by NIH, Hirschsprung’s disease occurs in nearly 1 in 5,000 newborns in North America.
  • However, the market in Asia Pacific is expected to expand at a faster CAGR during the forecast period owing to economic growth in emerging markets and continuous development in health care & pharmaceutical industries.

Key Players Operating in Global Hirschsprung’s Disease Treatment Market

The global Hirschsprung’s disease treatment market was highly fragmented in 2019. Key players operating in the global market are:

  • Pfizer
  • Sanofi
  • Bayer Healthcare
  • Johnson & Johnson
  • Merck & Co.
  • Novartis AG
  • Bristol-Myers Squibb
  • Astellas Pharma, Inc.
  • Eli Lilly and Company
  • Abbott
  • Panacea Biotech Ltd.
  • Cipla Ltd.
  • GlaxoSmithKline
  • Dr. Reddy’s Laboratories Ltd.
  • Baxter International

Global Hirschsprung’s Disease Treatment Market: Research Scope

Global Hirschsprung’s Disease Treatment Market, by Treatment Type

  • Surgery
  • Medication
    • Antibiotics
    • Toxins (onabotulinumtoxinA)
    • Others

Global Hirschsprung’s Disease Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Hirschsprungs Disease Treatment Market